Here we demonstrated significantly elevated CSF PGRN levels in RIS and MS patients during the clinically silent or non-relapsing phase, presumably suggesting ongoing inflammation, while only the later disease stages revealed an increased CSF NFL, thus mirroring axonal injury in addition. This evidence concerns the gene NEFL and myeloid sarcoma.